Travere Therapeutics, Inc. Common Stock (TVTX) Financials
Key financial figures for Travere Therapeutics, Inc. Common Stock (Q1 2026).
- Revenue
- $127M
- Net Income
- -$37M
- EPS
- $-0.40
- Total Assets
- $555M
- Operating Cash Flow
- -$40M
Full income statement, balance sheet, and cash flow for Travere Therapeutics, Inc. Common Stock on SentiSense.